ClinicalTrials.gov
ClinicalTrials.gov Menu

PET-CT for Squamous Cell Carcinoma (SCC) of the Neck Nodes Unknown Primary Malignancy

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT00530283
Recruitment Status : Completed
First Posted : September 17, 2007
Last Update Posted : January 19, 2012
Sponsor:
Collaborator:
Calgary Health Region
Information provided by:
AHS Cancer Control Alberta

Brief Summary:
Patients with squamous cell cancer of neck nodes but unknown primary will have a PET-CT scan prior to biopsies. The utility of PET-CT will be determined in this subset of patients.

Condition or disease Intervention/treatment
Squamous Cell Cancer Other: PET-CT

Study Type : Observational
Estimated Enrollment : 58 participants
Observational Model: Cohort
Time Perspective: Prospective
Official Title: The Clinical Utility of PET-CT in the Management of Squamous Cell Carcinoma of the Neck Nodes With Unknown Primary Malignancy
Study Start Date : August 2007
Actual Study Completion Date : July 2011

Group/Cohort Intervention/treatment
A
Patients with Squamous cell cancer of neck nodes, unknown primary
Other: PET-CT




Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Ages Eligible for Study:   18 Years and older   (Adult, Older Adult)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Sampling Method:   Non-Probability Sample
Study Population
18 years
Criteria

Inclusion Criteria:

  • squamous cell cancer of neck nodes with unknown primary site

Exclusion Criteria:

  • unable to tolerate PET-CT
  • unable to undergo examination under anaesthesia

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00530283


Locations
Canada, Alberta
Tom Baker Cancer Centre
Calgary, Alberta, Canada, T2N 4N2
Sponsors and Collaborators
Alberta Health Services
Calgary Health Region
Investigators
Principal Investigator: Harold Lau, M.D. AHS Cancer Control Alberta

ClinicalTrials.gov Identifier: NCT00530283     History of Changes
Other Study ID Numbers: 20682
First Posted: September 17, 2007    Key Record Dates
Last Update Posted: January 19, 2012
Last Verified: August 2011

Keywords provided by AHS Cancer Control Alberta:
Squamous
Unknown Primary
Patients with Squamous cell cancer neck nodes

Additional relevant MeSH terms:
Carcinoma, Squamous Cell
Neoplasms, Squamous Cell
Carcinoma
Neoplasms, Glandular and Epithelial
Neoplasms by Histologic Type
Neoplasms